Open AccessNew onset of Myasthenia Gravis in Patients with COVID-19: is it Causal or Coincidental?
Author(s) -
M. Berrada,
Zahra El Bidaoui,
Mohammed Amine Mouhdi,
M.A. Rafai,
Hicham El Otmani,
Bouchra El Moutawakil
Publication year - 2022
Publication title -
scholars journal of applied medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2347-954X
pISSN - 2320-6691
DOI - 10.36347/sjams.2022.v10i03.010
Subject(s) - myasthenia gravis , covid-19 , medicine , context (archaeology) , observational study , pandemic , immunology , virology , infectious disease (medical specialty) , disease , outbreak , biology , paleontology
COVID-19 pandemic is caused by highly infectious SARS-CoV-2. Observational studies have documented several neurological complications or associations either during or after the COVID-19. Some of them, have reported some case reports regarding COVID-19 in patients with a known history of myasthenia gravis (MG) but new onset of autoimmune MG in patients with COVID-19 is scarcely reported. Here, we report two novel cases of new-onset autoimmune MG following COVID-19 and describe the clinical and paraclinical findings in the context of other scarce reported cases.